Conditions that typically exclude GLP-1 candidacy - and that Omzo's clinical intake process is designed to screen for - include a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2 (MEN 2), a history of pancreatitis, and known hypersensitivity to semaglutide or any component of the medication
Furthermore, introduction of these agents into clinical practice has been accompanied by a shift in the focus of diabetes care from a glucose-centric to a cardiorenal risk-centric approach
They must have established written protocols for screening, prescribing, administering, and monitoring patients on these medications, and they must oversee the training and competency of any delegated staff (APRNs, PAs, RNs)
Light meals, steady hydration, and slower eating patterns help reduce early digestive symptoms
By enhancing liver health, GLP-1 plays a role in comprehensive metabolic health improvement